Lenalidomide for Adult Histiocyte Disorders

Clinical trial NCT02523040 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02523040
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Langerhans Cell Histiocytosis (LCH)Histiocytoses Erdheim-chester Disease Histiocytic Sarcoma (HS)

Start date: 2015-08-01
Primary completion: 2024-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.